Skip to main content

Day: May 9, 2025

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit secures a composition of matter patent from the Korean Intellectual Property Office for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and strategic partnerships.NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 09, 2025 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals”, “Conduit” or the “Company”) today announces that the Korean Intellectual Property Office (KIPO) has granted the composition of matter patent for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune diseases. This approval follows recent grants in the U.S., Japan and Australia and further strengthens Conduit’s global intellectual property position as it advances out-licensing discussions....

Continue reading

Vocodia Expands Business Plan to Include Crypto Asset Acquisition Powered by Predictive AI

BOCA RATON, Fla., May 09, 2025 (GLOBE NEWSWIRE) — Vocodia Holdings Corp. (OTCQB: VHAI), a leader in AI-driven voice automation and digital intelligence, announced today an update to its business plan to include the acquisition of crypto assets as part of its strategic growth initiatives. This move is supported by Vocodia’s proprietary Predictive AI technology, co-developed with its strategic partners, designed to identify and act on optimal digital asset opportunities. The company is currently in advanced negotiations with investment banks for an initial investment to support the first phase of this new initiative. “Our Predictive AI gives us a unique edge in the digital asset space,” said Brian Podolak, CEO of Vocodia. “We believe integrating crypto into our business model aligns with our long-term vision for value creation and...

Continue reading

REMINDER: Rogers Sugar Inc.: Conference Call – 2nd Quarter 2025 Results

MONTREAL, May 09, 2025 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (RSI) will be holding a conference call to discuss their 2025 second quarter results on Tuesday, May 13, 2025, at 8:00 a.m. (Eastern Time). The conference call will be chaired by Mr. Michael Walton, Chief Executive Officer and Mr. Jean-Sébastien Couillard, Chief Financial Officer. If you wish to participate, please dial 1-800-717-1738. A recording of the conference call will be accessible shortly after the conference, by dialing 1-888-660-6264, access code 72827#. This recording will be available until June 13, 2025. The discussion along with a presentation will be accessible through a webcast at the following address: https://onlinexperiences.com/Launch/QReg/ShowUUID=C31929AD-7ACD-4C0A-946F-CCEC356BD87D&LangLocaleID=1033 For further information: Jean-Sébastien Couillard...

Continue reading

PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumorsInterim analysis from Phase 2 PYNNACLE trial expected mid-2025; PMV plans to provide interim analysis data for approximately 50 patients with at least 18 weeks of follow-upCash, cash equivalents, and marketable securities of $165.8 million as of March 31, 2025, providing expected cash runway to end of 2026PRINCETON, N.J., May 09, 2025 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today reported financial results for the first quarter ended March 31, 2025, and provided a corporate...

Continue reading

NextNav Inc. Reports First Quarter 2025 Results and Operational Highlights

FCC releases Notice of Inquiry (NOI) with bipartisan 4-0 vote NextNav Announces Appointment of Rear Admirals H. Wyman Howard and Lorin Selby to its Board of Directors RESTON, Va., May 09, 2025 (GLOBE NEWSWIRE) — NextNav Inc. (NASDAQ: NN) a leader in next generation positioning, navigation, and timing (PNT) and 3D geolocation, today reported its financial results and operational updates for the quarter ended March 31, 2025. “During the quarter we saw continued FCC momentum with a unanimous vote in March to further explore PNT solutions, specifically including NextNav’s,” said NextNav’s CEO, Mariam Sorond. “We remain focused on executing against our goals and addressing an urgent national security need for a terrestrial complement and backup to GPS. We look forward to working with the FCC and the rest of the industry to enable PNT...

Continue reading

Ryman Hospitality Properties, Inc. Declares Second Quarter Dividend

NASHVILLE, Tenn., May 09, 2025 (GLOBE NEWSWIRE) — Ryman Hospitality Properties (NYSE: RHP) (the “Company”), today announced that the Board of Directors has authorized, and the Company has declared a second quarter cash dividend of $1.15 per share of common stock, to be paid on July 15, 2025, to stockholders of record as of June 30, 2025. About Ryman Hospitality Properties, Inc. Ryman Hospitality Properties, Inc. (NYSE: RHP) is a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and entertainment experiences. The Company’s holdings include Gaylord Opryland Resort & Convention Center; Gaylord Palms Resort & Convention Center; Gaylord Texan Resort & Convention Center; Gaylord National Resort & Convention Center; and Gaylord Rockies Resort & Convention...

Continue reading

Inuvo Posts Record Q1 2025 Revenue of $26.7M, up 57% Year-Over-Year

Management to host conference call at 8:30 AM ET, Friday, May 9, 2025 LITTLE ROCK, Ark., May 09, 2025 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today provided a business update and announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights:Revenue was a record $26.7 million; a 57% increase compared to $17.0 million in Q1. 2024; highest revenue in the Company’s history. Gross profit increased 41% to $21.1 million, compared to $14.9 million in Q1 2024. Net loss per share was $0.01 compared to $0.02 in the prior year.   Adjusted EBITDA loss was $22 thousand, compared to a loss of $1.0 million for Q1 2024.First Quarter 2025 Operational Highlights:The company launched the enhanced IntentKey Self-Serve...

Continue reading

Ocugen Provides Business Update with First Quarter 2025 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ETOCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026 Anticipate initiating OCU410ST Phase 2/3 pivotal confirmatory clinical trial for Stargardt disease mid- 2025MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today reported first quarter 2025 financial results along with a general business update. “All three of our novel modifier gene therapies are advancing through the clinic and we are on track to meet our goal of three Biologics License Application (BLA)/Marketing Authorization Application (MAA) filings in the next three years,” said Dr. Shankar Musunuri, Chairman,...

Continue reading

Plains All American Reports First-Quarter 2025 Results

HOUSTON, May 09, 2025 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported first-quarter 2025 results and provided the following highlights: First-Quarter ResultsReported net income attributable to PAA of $443 million and net cash provided by operating activities of $639 million Delivered Adjusted EBITDA attributable to PAA of $754 million Exited the quarter with 3.3x leverage ratio, toward the low end of our target range of 3.25x – 3.75x (includes previously announced and closed transactions) Paid a quarterly cash distribution of $0.38 per unit ($1.52 per unit annualized), representing a current distribution yield of ~9.0%Business HighlightsPlains acquired the remaining 50% interest in Cheyenne Pipeline, enhancing our integration from the Guernsey...

Continue reading

illumin Reports First Quarter 2025 Financial Results

First Quarter Revenue of $29.1 Million up 17% YoYExchange Service Revenue up 148% YoY (All monetary figures are expressed in Canadian dollars unless otherwise stated) TORONTO, May 09, 2025 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX: ILLM and OTCQB: ILLMF) (“illumin” or the “Company”), the advertising technology platform that enables you to win your next customer, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 HighlightsFirst quarter 2025 revenue rose 17% year-over-year to $29.1 million, driven by higher Exchange service revenue, partially offset by lower Managed service revenue. Self-service revenue was $8.4 million, up slightly compared with the year ago period and represented 29% of total revenue. The Company on-boarded 18 net new Self-service clients during the quarter,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.